547 related articles for article (PubMed ID: 27392941)
1. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
5. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
6. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
7. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
8. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
[TBL] [Abstract][Full Text] [Related]
10. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
[TBL] [Abstract][Full Text] [Related]
11. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
Liu Z; Tao Z; Zhang Q; Wan S; Zhang F; Zhang Y; Wu G; Wang J
Cancer Chemother Pharmacol; 2018 Apr; 81(4):687-695. PubMed ID: 29392452
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
13. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
14. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
15. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
Chen C; Sun W; Wang X; Wang Y; Wang P
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
[TBL] [Abstract][Full Text] [Related]
16. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
17. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency.
Ghosh S; Dutta S; Sarkar A; Kundu M; Sil PC
Colloids Surf B Biointerfaces; 2021 Jan; 197():111404. PubMed ID: 33142257
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy.
Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078
[TBL] [Abstract][Full Text] [Related]
20. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
